Efficacy Study of the Product "CHF 1535" Versus Beclomethasone (BDP) and Free Combo in Asthmatic Children
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate that CHF 1535 in pressurized metered dose inhaler
(pMDI) is non-inferior to the corresponding dose of free combination of Beclomethasone (BDP)
and Formoterol Fumarate (FF) and superior to the corresponding dose of BDP in terms of lung
functions in asthmatic children patients.